Page 120 - Read Online

Obeid et al. Vessel Plus 2022;6:43 https://dx.doi.org/10.20517/2574-1209.2021.136 Page 13 of 14

intracranial hemorrhage in patients with advanced heart failure and a continuous-flow left ventricular assist device. Circ J
2020;84:949-57. DOI PubMed
30. Deshmukh A, Bhatia A, Anyanwu E, et al. Incidence and outcomes of postoperative atrial fibrillation after left ventricular assist
device. ASAIO J 2018;64:581-5. DOI PubMed PMC
31. Noll AE, Adewumi J, Amuthan R, et al. Atrial tachyarrhythmias among patients with left ventricular assist devices: prevalence,
clinical outcomes, and impact of rhythm control strategies. JACC Clin Electrophysiol 2019;5:459-66. DOI PubMed
32. Gonuguntla K, Patil S, Rojulpote C, et al. A population based analysis of trends, risk factors and outcomes associated with
gastrointestinal bleeding in patients with left ventricular assist devices. Am J Cardiovasc Dis 2020;10(3):247-257. PubMed PMC
33. Imamura T, Kinugawa K, Ono M, et al. Implication of preoperative existence of atrial fibrillation on hemocompatibility-related
adverse events during left ventricular assist device support. Circ J 2019;83:1286-92. DOI PubMed
34. Joy PS, Kumar G, Guddati AK, Bhama JK, Cadaret LM. Risk factors and outcomes of gastrointestinal bleeding in left ventricular
assist device recipients. Am J Cardiol 2016;117:240-4. DOI PubMed
35. Morgan JA, Go PH, Xuereb L, et al. Outcomes on continuous flow left ventricular assist devices: a single institutional 9-year
experience. Ann Thorac Surg 2016;102:1266-73. DOI PubMed
36. Xuereb L, Go PH, Kaur B, et al. Impact of preoperative atrial fibrillation on postoperative thromboembolic events after left ventricular
assist device implantation. Ann Thorac Surg 2016;102:1543-9. DOI PubMed
37. Acharya D, Loyaga-Rendon R, Morgan CJ, et al. Intermacs analysis of stroke during support with continuous-flow left ventricular
assist devices: risk factors and outcomes. JACC Heart Fail 2017;5:703-11. DOI PubMed PMC
38. Hui J, Mauermann WJ, Stulak JM, Hanson AC, Maltais S, Barbara DW. Intensive care unit readmission after left ventricular assist
device implantation: causes, associated factors, and association with patient mortality. Anesth Analg 2019;128:1168-74. DOI PubMed
39. Hawkins RB, Mehaffey JH, Guo A, et al. Virginia Cardiac Services Quality Initiative. Postoperative atrial fibrillation is associated
with increased morbidity and resource utilization after left ventricular assist device placement. J Thorac Cardiovasc Surg
2018;156:1543-1549. DOI PubMed PMC
40. Teuteberg JJ, Slaughter MS, Rogers JG, et al. ADVANCE Trial Investigators. The HVAD left ventricular assist device: risk factors for
neurological events and risk mitigation strategies. JACC Heart Fail 2015;3:818-28. DOI PubMed
41. Xia Y, Stern D, Friedmann P, Goldstein D. Preoperative atrial fibrillation may not increase thromboembolic events in left ventricular
assist device recipients on midterm follow-up. J Heart Lung Transplant 2016;35:906-12. DOI
42. Martins RP, Leclercq C, Bourenane H, et al. Incidence, predictors, and clinical impact of electrical storm in patients with left
ventricular assist devices: new insights from the ASSIST-ICD study. Heart Rhythm 2019;16:1506-12. DOI PubMed
43. Kurihara C, Critsinelis A, Kawabori M, Sugiura T, Civitello AB, Morgan JA. Effect of preoperative atrial fibrillation on patients with
chronic heart failure who undergo long-term continuous-flow LVAD implantation. ASAIO J 2018;64:594-600. DOI PubMed
44. Nassif ME, LaRue SJ, Raymer DS, et al. Relationship between anticoagulation intensity and thrombotic or bleeding outcomes among
outpatients with continuous-flow left ventricular assist devices. Circ Heart Fail 2016;9:e002680. DOI PubMed PMC
45. Izzy S, Rubin DB, Ahmed FS, et al. Cerebrovascular accidents during mechanical circulatory support: new predictors of ischemic and
hemorrhagic strokes and outcome. Stroke 2018;49:1197-203. DOI
46. Brisco MA, Sundareswaran KS, Milano CA, et al. HeartMate II Clinical Investigators. Incidence, risk, and consequences of atrial
arrhythmias in patients with continuous-flow left ventricular assist devices. J Card Surg 2014;29:572-80. DOI PubMed
47. Morris AA, Pekarek A, Wittersheim K, et al. Gender differences in the risk of stroke during support with continuous-flow left
ventricular assist device. J Heart Lung Transplant 2015;34:1570-7. DOI PubMed
48. Dang NC, Topkara VK, Kim BT, Mercando ML, Kay J, Naka Y. Clinical outcomes in patients with chronic congestive heart failure
who undergo left ventricular assist device implantation. J Thorac Cardiovasc Surg 2005;130:1302-9. DOI PubMed
49. Kittipibul V, Rattanawong P, Kewcharoen J, Chongsathidkiet P, Vutthikraivit W, Kanjanahattakij N. Atrial fibrillation is not
associated with thromboembolism in left ventricular assist device patients: A Systematic Review and Meta-Analysis. ASAIO J
2019;65:456-64. DOI
50. Tantrachoti P, Klomjit S, Vutthikraivit W, Prieto S, Gongora E, Nair N. Impact of preoperative atrial fibrillation in patients with left
ventricular assist device: a systematic review and meta-analysis. Artif Organs 2019;43:1135-43. DOI PubMed
51. Usman MS, Ahmed S, Yamani N, et al. Meta-analysis of the effect of preoperative atrial fibrillation on outcomes after left ventricular
assist device implantation. Am J Cardiol 2019;124:158-62. DOI PubMed
52. Efimova E, Fischer J, Bertagnolli L, et al. Predictors of ventricular arrhythmia after left ventricular assist device implantation: a large
single-center observational study. Heart Rhythm 2017;14:1812-9. DOI PubMed
53. Hu RTC, Broad JD, Osawa EA, et al. 30-Day outcomes post Veno-Arterial Extra Corporeal Membrane Oxygenation (VA-ECMO)
after cardiac surgery and predictors of survival. Heart Lung Circ 2020;29:1217-25. DOI PubMed
54. Vigneshwar NG, Kohtz PD, Lucas MT, et al. Clinical predictors of in-hospital mortality in venoarterial extracorporeal membrane
oxygenation. J Card Surg 2020;35:2512-21. DOI PubMed
55. Sonu G, Rupak D, Bishoy H, et al. The impact of atrial fibrillation on in-hospital outcomes in patients with acute myocardial infarction
complicated by cardiogenic shock undergoing coronary revascularization with percutaneous ventricular assist device support. J Atr
Fibrillation 2020;12:2179. DOI PubMed PMC
56. Abdullah KQA, Roedler JV, Vom Dahl J, et al. Cardiac arrhythmias in survivors of sudden cardiac death requiring impella assist
device therapy. J Clin Med 2021;10:1393. DOI PubMed PMC